492 related articles for article (PubMed ID: 30283440)
1. The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.
Lu HY; Bauman BM; Arjunaraja S; Dorjbal B; Milner JD; Snow AL; Turvey SE
Front Immunol; 2018; 9():2078. PubMed ID: 30283440
[TBL] [Abstract][Full Text] [Related]
2. Germline CBM-opathies: From immunodeficiency to atopy.
Lu HY; Biggs CM; Blanchard-Rohner G; Fung SY; Sharma M; Turvey SE
J Allergy Clin Immunol; 2019 May; 143(5):1661-1673. PubMed ID: 31060714
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.
Lork M; Staal J; Beyaert R
Cell Immunol; 2019 Jun; 340():103877. PubMed ID: 30514565
[TBL] [Abstract][Full Text] [Related]
4. BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation.
Seeholzer T; Kurz S; Schlauderer F; Woods S; Gehring T; Widmann S; Lammens K; Krappmann D
Front Immunol; 2018; 9():2695. PubMed ID: 30515170
[TBL] [Abstract][Full Text] [Related]
5. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
[TBL] [Abstract][Full Text] [Related]
6. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.
David L; Li Y; Ma J; Garner E; Zhang X; Wu H
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1499-1504. PubMed ID: 29382759
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Genetic Heterogeneity of
Israel L; Mellett M
Front Immunol; 2018; 9():2239. PubMed ID: 30386326
[TBL] [Abstract][Full Text] [Related]
8. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.
Pérez de Diego R; Sánchez-Ramón S; López-Collazo E; Martínez-Barricarte R; Cubillos-Zapata C; Ferreira Cerdán A; Casanova JL; Puel A
J Allergy Clin Immunol; 2015 Nov; 136(5):1139-49. PubMed ID: 26277595
[TBL] [Abstract][Full Text] [Related]
9. Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions.
Staal J; Driege Y; Haegman M; Borghi A; Hulpiau P; Lievens L; Gul IS; Sundararaman S; Gonçalves A; Dhondt I; Pinzón JH; Braeckman BP; Technau U; Saeys Y; van Roy F; Beyaert R
Front Immunol; 2018; 9():1136. PubMed ID: 29881386
[TBL] [Abstract][Full Text] [Related]
10. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
[TBL] [Abstract][Full Text] [Related]
11. Molecular architecture and regulation of BCL10-MALT1 filaments.
Schlauderer F; Seeholzer T; Desfosses A; Gehring T; Strauss M; Hopfner KP; Gutsche I; Krappmann D; Lammens K
Nat Commun; 2018 Oct; 9(1):4041. PubMed ID: 30279415
[TBL] [Abstract][Full Text] [Related]
12. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
Juilland M; Thome M
Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
[TBL] [Abstract][Full Text] [Related]
13. Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist.
Cheng J; Maurer LM; Kang H; Lucas PC; McAllister-Lucas LM
Cell Immunol; 2020 Sep; 355():104158. PubMed ID: 32721634
[TBL] [Abstract][Full Text] [Related]
14. A
De Bruyne M; Hoste L; Bogaert DJ; Van den Bossche L; Tavernier SJ; Parthoens E; Migaud M; Konopnicki D; Yombi JC; Lambrecht BN; van Daele S; Alves de Medeiros AK; Brochez L; Beyaert R; De Baere E; Puel A; Casanova JL; Goffard JC; Savvides SN; Haerynck F; Staal J; Dullaers M
Front Immunol; 2018; 9():2366. PubMed ID: 30429846
[No Abstract] [Full Text] [Related]
15. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease.
Bedsaul JR; Carter NM; Deibel KE; Hutcherson SM; Jones TA; Wang Z; Yang C; Yang YK; Pomerantz JL
Front Immunol; 2018; 9():2105. PubMed ID: 30283447
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency.
Lu HY; Sharma M; Sharma AA; Lacson A; Szpurko A; Luider J; Dharmani-Khan P; Shameli A; Bell PA; Guilcher GMT; Lewis VA; Vasquez MR; Desai S; McGonigle L; Murguia-Favela L; Wright NAM; Sergi C; Wine E; Overall CM; Suresh S; Turvey SE
J Allergy Clin Immunol; 2021 Dec; 148(6):1559-1574.e13. PubMed ID: 33872653
[TBL] [Abstract][Full Text] [Related]
18. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
Qiao Q; Yang C; Zheng C; Fontán L; David L; Yu X; Bracken C; Rosen M; Melnick A; Egelman EH; Wu H
Mol Cell; 2013 Sep; 51(6):766-79. PubMed ID: 24074955
[TBL] [Abstract][Full Text] [Related]
19. MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells.
Gehring T; Erdmann T; Rahm M; Graß C; Flatley A; O'Neill TJ; Woods S; Meininger I; Karayel O; Kutzner K; Grau M; Shinohara H; Lammens K; Feederle R; Hauck SM; Lenz G; Krappmann D
Cell Rep; 2019 Oct; 29(4):873-888.e10. PubMed ID: 31644910
[TBL] [Abstract][Full Text] [Related]
20. A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells.
Yin H; Karayel O; Chao YY; Seeholzer T; Hamp I; Plettenburg O; Gehring T; Zielinski C; Mann M; Krappmann D
Cell Mol Life Sci; 2022 Jan; 79(2):112. PubMed ID: 35099607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]